Sign In
Buy JJSF
$75.77
-0.360 (-0.473%)
At Close: Jun 03, 2026
Johnson & Johnson halts Covid-19 vaccine trial due to unexplained illness
02:39am, Thursday, 15'th Oct 2020
by BLOOMBERG
Johnson & Johnson halted clinical trials of its Covid-19 vaccine after a participant fell ill, the second time that a front-runner developer has paused testing in the race to create a
Johnson & Johnson halted clinical trials of its Covid-19 vaccine after a participant fell ill, the second time that a front-runner developer has paused testing in the race to create a
The Zacks Analyst Blog Highlights: JNJ, Eli Lilly, Merck, AbbVie and GSK
12:00am, Thursday, 15'th Oct 2020
Stocks Analysis by Zacks Investment Research covering: S&P 500, Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline PLC ADR. Read Zacks Investment Research's latest article on Investing.com
Race for coronavirus cure hits reality as clinic complications mount
04:37pm, Wednesday, 14'th Oct 2020
Regulators and drugmakers have faced questions about whether political pressure was overwhelming scientific rigor ahead of the presidential election on Nov. 3
Explained: Why Johnson & Johnson, Eli Lilly have halted late-stage Covid-19 clinical trials
04:00pm, Wednesday, 14'th Oct 2020
Johnson & Johnson became the second company after AstraZeneca to have halted Covid-19 vaccine trials. Last month, Oxford vaccine trials were halted after one of the participants in the UK developed an
J&J Offers Up To $5B In US Opioid Addiction Settlement
03:26pm, Wednesday, 14'th Oct 2020
Johnson & Johnson said it will contribute up to an additional $1 billion for a potential settlement agreement to resolve US opioid lawsuits which
Covid-19 Drug Issues Show Investors Shouldn’t Try to Pick One Winner
02:00pm, Wednesday, 14'th Oct 2020
The Benchmark Group says testing halts such as the one Eli Lilly announced Tuesday show the need for diversification.
Race for coronavirus treatment hits reality as complications mount
11:00am, Wednesday, 14'th Oct 2020
The sprint to find medical breakthroughs to contain Covid-19 stumbled this week, as a pair of pharmaceutical giants working to develop treatments and vaccines suffered setbacks in the clinic
Here’s evidence that putting customers and employees first turns out to be profitable for a company’s stockholders too
10:55am, Wednesday, 14'th Oct 2020
Coveted high-quality shareholders are drawn to companies whose CEOs agree with Business Roundtable’s purpose, writes Lawrence Cunningham.
Johnson & Johnson dépasse les estimations de Wall Street au T3 | Invezz
09:38am, Wednesday, 14'th Oct 2020
J&J rapporte 16,27 milliards £ de revenus et 1,70 £ de BPA ajusté au T3 et relève ses prévisions concernant le BPA ajusté et les revenus annuels.
Coronavirus LIVE Updates: Two late-stage Covid-19 medical trials have been paused in the space of 24 hours over potential safety concerns, the latest setbacks to scientists in the long fight against t
J&J hopes covid-19 vaccine trial will restart shortly
06:16am, Wednesday, 14'th Oct 2020
Executives express optimism that clinical trials can resume soon, but say they know little about the illness that prompted the halt
J&J vaccine pause shows challenges still ahead for covid-19 shots
04:58am, Wednesday, 14'th Oct 2020
Halt of trials for two of four of the West’s most advanced vaccines tempers global hopes
Race for coronavirus cure hits reality as pharmaceutical giants suffer clinic setbacks
01:06am, Wednesday, 14'th Oct 2020
WASHINGTON (BLOOMBERG) - The sprint to find medical breakthroughs to contain Covid-19 stumbled this week, as a pair of pharmaceutical giants working to develop treatments and vaccines suffered setback
Johnson & Johnson’s $100 Million Baby Powder Lawsuit Settlement Is Overdue For Black & Hispanic Women
12:00am, Wednesday, 14'th Oct 2020
Facing almost 20,000 lawsuits by women who blame Johnson & Johnson’s talcum powder for causing cancer finally has a $100 million settlement from the manufacturer. The company new of growing cancer c
Race for coronavirus cure hits reality as clinic complications mount
11:58pm, Tuesday, 13'th Oct 2020
The US has poured nearly $18 billion into Operation Warp Speed, its program designed to hasten the development of virus drugs and inoculations.The need to find viable treatments and ways to arrest the
